Cite
HARVARD Citation
Chan, J. et al. (2021). Cost‐effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosis. Journal of viral hepatitis. 28 (2), pp. 260-267. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chan, J. et al. (2021). Cost‐effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosis. Journal of viral hepatitis. 28 (2), pp. 260-267. [Online].